NCT05241899 2022-02-16A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) CancerThe First Affiliated Hospital of Zhengzhou UniversityPhase 2 Unknown56 enrolled